financetom
Business
financetom
/
Business
/
Amazon moves Karnataka High Court seeking stay on CCI probe
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amazon moves Karnataka High Court seeking stay on CCI probe
Feb 10, 2020 7:55 AM

Amazon on Monday moved the Karantaka High Court with a writ petition seeking to set aside the January 13 order of the Competition Commission of India (CCI) for a probe into alleged anti-competitive practices by Amazon and Flipkart.

Share Market Live

NSE

The ecommerce company filed the petition seeking that the CCI order be quashed or set aside. It also sought an interim stay on the order.

In the writ petition, Amazon called the findings by the regulator as 'perverse, arbitrary, and untenable in law'.

The global tech giant added that in the absence of an interim stay, 'irreparable loss and injury would be caused' to the company and its reputation and goodwill.

CCI ordered the probe based on a complaint filed by Delhi Vyapar Mahasangh, a group representing brick and mortar small businesses, and had instructed the director general of the agency to submit the investigation report within 60 days from January 13.

The competition watchdog had also ordered a probe into alleged predatory deep discounts and exclusive launches offered by online sellers Amazon and Flipkart on mobile phones sold in the country.

CCI added that four alleged anti-competitive practices in the complaint – exclusive launch of mobile phones, preferred sellers in these online platforms’ deep discounting and preferential listing and promotion of private labels.

Amazon is yet to respond to the queries that CNBC TV 18 sent requesting its comment on the development.

First Published:Feb 10, 2020 4:55 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Baldwin Insurance Group Insider Sold Shares Worth $3,925,063, According to a Recent SEC Filing
Baldwin Insurance Group Insider Sold Shares Worth $3,925,063, According to a Recent SEC Filing
Aug 12, 2024
03:33 AM EDT, 08/12/2024 (MT Newswires) -- James Morgan Roche, President, The Baldwin Group and Chief Executive Officer, Underwriting, Capacity and Technology Operations, on August 08, 2024, sold 93,596 shares in Baldwin Insurance Group ( BWIN ) for $3,925,063. Following the Form 4 filing with the SEC, Roche has control over a total of 339,903 shares of the company, with...
Klaviyo Insider Sold Shares Worth $1,813,800, According to a Recent SEC Filing
Klaviyo Insider Sold Shares Worth $1,813,800, According to a Recent SEC Filing
Aug 12, 2024
03:25 AM EDT, 08/12/2024 (MT Newswires) -- Amanda Whalen, Chief Financial Officer, on August 09, 2024, sold 60,000 shares in Klaviyo ( KVYO ) for $1,813,800. Following the Form 4 filing with the SEC, Whalen has control over a total of 435,993 shares of the company, with 435,993 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1835830/000199113124000003/xslF345X03/wk-form4_1723246372.xml ...
Murphy USA Insider Sold Shares Worth $6,920,469, According to a Recent SEC Filing
Murphy USA Insider Sold Shares Worth $6,920,469, According to a Recent SEC Filing
Aug 12, 2024
03:34 AM EDT, 08/12/2024 (MT Newswires) -- Robert Madison Murphy, Director, on August 08, 2024, sold 13,454 shares in Murphy USA ( MUSA ) for $6,920,469. Following the Form 4 filing with the SEC, Murphy has control over a total of 426,272 shares of the company, with 426,272 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1573516/000112760224021962/xslF345X03/form4.xml Price: 510.90, Change: +0.53, Percent Change: +0.10...
Axsome Therapeutics Insider Sold Shares Worth $4,022,488, According to a Recent SEC Filing
Axsome Therapeutics Insider Sold Shares Worth $4,022,488, According to a Recent SEC Filing
Aug 12, 2024
03:31 AM EDT, 08/12/2024 (MT Newswires) -- Mark L. Jacobson, Chief Operating Officer, on August 09, 2024, sold 47,739 shares in Axsome Therapeutics ( AXSM ) for $4,022,488. Following the Form 4 filing with the SEC, Jacobson has control over a total of 5,783 shares of the company, with 5,783 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1579428/000095017024094967/xslF345X03/ownership.xml Price: 79.59, Change: -3.50,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved